NEW YORK--(BUSINESS WIRE)--Colbeck Capital Management (“Colbeck”) today announced its latest support of the Children’s Tumor Foundation (“CTF” or the “Foundation”) through sponsorship of the Foundation’s 2024 National Gala. The annual event, to be held on November 18 at Gotham Hall in New York City, helps to raise important funds to advance research and care developments while honoring individuals who have made significant contributions to the mission of ending NF (short for neurofibromatosis and schwannomatosis).
At this year’s gala, supporters like Jason Colodne and Colbeck Capital will honor the achievements of Kimberly Snipes, Sarah Wengel, Allison and Kip Clarke, and Leanna Scaglione, who will be recognized as the 2025 NF National Ambassador. This award recognizes the courage of an individual living with NF, who furthers the Foundation’s goals of expanding research, promoting public awareness, and collaborating on innovative treatment solutions in support of patients and families affected by NF.
As the drug discovery engine for NF, the Children’s Tumor Foundation brings together patients, doctors, scientists, and pharma to drive treatments, advance care, and deliver faster results for millions affected by neurofibromatosis or schwannomatosis. CTF’s patient-first collaborative approach accelerates drug development and brings life-changing therapies to patients faster – driven by its mission to end NF. To learn more about the gala, please click here.
About Colbeck Capital Management
Colbeck Capital Management (colbeck.com) is a leading, middle-market private credit manager focused on strategic lending. Colbeck lends to companies going through periods of transition, providing creative capital solutions and risk mitigation strategies. Leveraging its deep relationships, Colbeck sponsors its portfolio companies through consistent engagement with management teams in areas such as finance, capital markets and growth strategies, distinguishing itself from traditional lenders. Colbeck was founded in 2009 by Jason Colodne and Jason Beckman, and its principals have extensive experience investing through different market cycles at leading institutions, including Goldman Sachs and Morgan Stanley.
